Literature DB >> 11872547

Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial.

Paola Dey1, Nigel Bundred, Alan Gibbs, Penny Hopwood, Andrew Baildam, Caroline Boggis, Marilyn James, Fiona Knox, Vicki Leidecker, Ciarán Woodman.   

Abstract

OBJECTIVE: To determine the cost to the NHS and the impact on anxiety of a one stop clinic for assessing women with suspected breast cancer. STUDY
DESIGN: Randomised controlled trial. PARTICIPANTS: Women aged 35 or over referred with a breast lump. STUDY
SETTING: Teaching hospital, north west England.
INTERVENTIONS: Women were randomly allocated to attend a one stop clinic or a dedicated breast clinic. OUTCOME MEASURES: Reduction in mean anxiety from baseline at 24 hours after the first visit and at 3 weeks and 3 months after diagnosis; mean cost per patient.
RESULTS: 670 women were randomised. Compared with women who attended the dedicated clinic, patients attending the one stop clinic were less anxious 24 hours after the visit (adjusted mean change in state anxiety _5.7 (95% confidence interval _8.4 to _3.0)) but not at 3 weeks or 3 months after diagnosis. The additional cost to the NHS of a one stop attendance was pound 32 per woman; this was largely explained by greater cytopathological and radiological staff costs.
CONCLUSION: One stop clinics may not be justified in terms of a reduction in short term anxiety.

Entities:  

Mesh:

Year:  2002        PMID: 11872547      PMCID: PMC67764     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

Review 1.  Repeated measures in clinical trials: simple strategies for analysis using summary measures.

Authors:  S Senn; L Stevens; N Chaturvedi
Journal:  Stat Med       Date:  2000-03-30       Impact factor: 2.373

Review 2.  The impact of patient treatment preferences on the interpretation of randomised controlled trials.

Authors:  K McPherson; A Britton
Journal:  Eur J Cancer       Date:  1999-10       Impact factor: 9.162

Review 3.  The emergence of the 'waiting game': a critical examination of the psychosocial issues in diagnosing breast cancer.

Authors:  K Poole
Journal:  J Adv Nurs       Date:  1997-02       Impact factor: 3.187

4.  Satisfaction with nurse specialists in breast care clinics. Nurse led clinics may actually cost more.

Authors:  J M Dixon; J Lamb; G Stones; A Rahman; D Mitchell
Journal:  BMJ       Date:  1998-11-07

5.  Responses of consecutive patients to reassurance after gastroscopy: results of self administered questionnaire survey.

Authors:  M P Lucock; S Morley; C White; M D Peake
Journal:  BMJ       Date:  1997-09-06

Review 6.  How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population?

Authors:  H A Moss; P D Britton; C D Flower; A H Freeman; D J Lomas; R M Warren
Journal:  Clin Radiol       Date:  1999-10       Impact factor: 2.350

Review 7.  Randomised consent designs in cancer clinical trials.

Authors:  D G Altman; J Whitehead; M K Parmar; S P Stenning; P M Fayers; D Machin
Journal:  Eur J Cancer       Date:  1995-11       Impact factor: 9.162

Review 8.  The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening.

Authors:  W Teh; A R Wilson
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

9.  One-stop diagnosis for symptomatic breast disease.

Authors:  G P Gui; W H Allum; N M Perry; C A Wells; O M Curling; A McLean; R Oommen; R Carpenter
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

10.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

View more
  15 in total

1.  Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results?

Authors:  M Jeffers
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

2.  Mammography in symptomatic women attending a rapid diagnosis breast clinic: a prospective study.

Authors:  M J P Biggs; D Ravichandran
Journal:  Ann R Coll Surg Engl       Date:  2006-05       Impact factor: 1.891

3.  Cost analysis of breast cancer diagnostic assessment programs.

Authors:  G N Honein-AbouHaidar; J S Hoch; M J Dobrow; T Stuart-McEwan; D R McCready; A R Gagliardi
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

4.  Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians.

Authors:  R Heisey; M Clemons; L Granek; K Fergus; S Hum; B Lord; D R McCready; B Fitzgerald
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

5.  Community-based HIV clinical trials: an integrated approach in underserved, rural, minority communities.

Authors:  Giselle Corbie-Smith; Malika Roman Isler; Margaret Shandor Miles; Bahby Banks
Journal:  Prog Community Health Partnersh       Date:  2012

6.  General practitioner referrals to one-stop clinics for symptoms that could be indicative of cancer: a systematic review of use and clinical outcomes.

Authors:  Claire Friedemann Smith; Alice Tompson; Gea A Holtman; Clare Bankhead; Fergus Gleeson; Daniel Lasserson; Brian D Nicholson
Journal:  Fam Pract       Date:  2019-05-23       Impact factor: 2.267

7.  An initial experience with rapid microwave processing in the one-stop breast clinic.

Authors:  Edward Parkin; Sandip Hindocha; Daren Subar; Imran Mehrban; Janet Walls
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

8.  Study comparing two types of screening provision for people with von Hippel-Lindau disease.

Authors:  Lindsay Fraser; Sally Watts; Anna Cargill; Stephen Sutton; Shirley Hodgson
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

9.  Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.

Authors:  Li Jiang; Julie Gilbert; Hugh Langley; Rahim Moineddin; Patti A Groome
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-10       Impact factor: 3.240

10.  Cancer diagnostic assessment programs: standards for the organization of care in Ontario.

Authors:  M Brouwers; T K Oliver; J Crawford; P Ellison; W K Evans; A Gagliardi; J Lacourciere; D Lo; V Mai; S McNair; T Minuk; L Rabeneck; C Rand; J Ross; J Smylie; J Srigley; H Stern; M Trudeau
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.